FCCC LOGO Faculty Publications
Kumar SK , Callander NS , Hillengass J , Liedtke M , Baljevic M , Campagnaro E , Castillo JJ , Chandler JC , Cornell RF , Costello C , Efebera Y , Faiman M , Garfall A , Godby K , Holmberg L , Htut M , Huff CA , Kang Y , Landgren O , Malek E , Martin T , Omel J , Raje N , Sborov D , Singhal S , Stockerl-Goldstein K , Tan C , Weber D , Johnson-Chilla A , Keller J , Kumar R
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Journal of the National Comprehensive Cancer Network : JNCCN. 2019 Oct 1;17(10) :1154-1165
Back to previous list
Abstract
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.
Notes
Export Date: 1 November 2019